Apimeds Pharmaceuticals US, Inc (APUS )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol APUS
- Company Apimeds Pharmaceuticals US, Inc
- Price $1.4
- Changes Percentage 3.7
- Change 0.05
- Day Low $1.35
- Day High $1.5
- Year High $40.31
- Year Low $1.24
- Market Cap $1,697,757
- Price Avg 50 EMA (D) $2.7
- Price Avg 200 EMA (D) $14.84
- Exchange AMEX
- Volume 65,982
- Average Volume 131,492
- Open $1.35
- Previous Close $1.35
- EPS -2.78
- PE -0.49
- Earnings Announcement 2026-05-04 04:00:00
- Shares Outstanding $1,257,598
Company brief: APIMEDS PHARMACEUTICALS US, INC (APUS )
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Mr. Erik C. Emerson
- https://www.apimedsus.com
- US
- N/A
- 11-30--0001
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.